Skip to main content
Erschienen in: Abdominal Radiology 11/2020

18.05.2020 | Interventional Radiology

The effect of tumor location on long-term results of microwave ablation for early-stage hepatocellular carcinoma

verfasst von: Jian-ping Dou, Zhi-yu Han, Zhi-gang Cheng, Fang-yi Liu, Xiao-ling Yu, Jie Yu, Ping Liang

Erschienen in: Abdominal Radiology | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

To analyze the influence of tumor location, including tumor adjacency and located segments on long-term survival outcomes for patients with solitary hepatocellular carcinoma (HCC) after microwave ablation (MWA).

Methods

This retrospective study evaluated 850 patients. The hepatic segments where the tumor is located, tumor adjacency (important tissues adjacent to tumor) and other clinical characteristics were collected. Overall survival (OS), local tumor progression (LTP) and disease-free survival (DFS) were compared and analyzed. Influence of tumor location was evaluated by multi-models and the effect of adjacency for OS, LTP, and DFS in different segments was analyzed by stratification analysis.

Results

The OS, LTP, and DFS rates were similar in different hepatic segments, so were in high risk and safe locations. In multi-models, HCC in segment 8 showed lower death rate of 43% than that in segment 2 (HR 0.57; P = 0.01) and tumors in segment 6 seemed to have lower LTP rate. Tumors in high-risk locations were risk factors for OS, LTP, and DFS compared with tumors in safe locations, but all differences were not significant in different models. The effects of tumor adjacency on survival outcomes among subgroups of segments were limited.

Conclusion

The tumor adjacency was not a prognostic factor of survival outcomes for patients with solitary tumors after MWA, but tumors in segment 8 seemed to better OS rate than tumors in other segments.
Literatur
1.
Zurück zum Zitat Villanueva A. Hepatocellular Carcinoma. N Engl J Med 2019;380:1450-1462.CrossRef Villanueva A. Hepatocellular Carcinoma. N Engl J Med 2019;380:1450-1462.CrossRef
2.
Zurück zum Zitat Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, Pracht M, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2017;389:56-66.CrossRef Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, Pracht M, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2017;389:56-66.CrossRef
3.
Zurück zum Zitat El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C, Kim TY, et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet 2017;389:2492-2502.CrossRef El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C, Kim TY, et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet 2017;389:2492-2502.CrossRef
4.
Zurück zum Zitat Liang P, Yu J, Lu MD, Dong BW, Yu XL, Zhou XD, Hu B, et al. Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancy. World J Gastroenterol 2013;19:5430-5438.CrossRef Liang P, Yu J, Lu MD, Dong BW, Yu XL, Zhou XD, Hu B, et al. Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancy. World J Gastroenterol 2013;19:5430-5438.CrossRef
5.
Zurück zum Zitat Thamtorawat S, Hicks RM, Yu J, Siripongsakun S, Lin WC, Raman SS, McWilliams JP, et al. Preliminary Outcome of Microwave Ablation of Hepatocellular Carcinoma: Breaking the 3-cm Barrier? J Vasc Interv Radiol 2016;27:623-630.CrossRef Thamtorawat S, Hicks RM, Yu J, Siripongsakun S, Lin WC, Raman SS, McWilliams JP, et al. Preliminary Outcome of Microwave Ablation of Hepatocellular Carcinoma: Breaking the 3-cm Barrier? J Vasc Interv Radiol 2016;27:623-630.CrossRef
6.
Zurück zum Zitat Chen J, Peng K, Hu D, Shen J, Zhou Z, Xu L, Chen J, et al. Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation. Cancers (Basel) 2018;10. Chen J, Peng K, Hu D, Shen J, Zhou Z, Xu L, Chen J, et al. Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation. Cancers (Basel) 2018;10.
7.
Zurück zum Zitat Yang W, Yan K, Wu GX, Wu W, Fu Y, Lee JC, Zhang ZY, et al. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes. World J Gastroenterol 2015;21:1554-1566.CrossRef Yang W, Yan K, Wu GX, Wu W, Fu Y, Lee JC, Zhang ZY, et al. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes. World J Gastroenterol 2015;21:1554-1566.CrossRef
8.
Zurück zum Zitat Kang TW, Lim HK, Lee MW, Kim YS, Choi D, Rhim H. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes. Radiology 2014;270:888-899.CrossRef Kang TW, Lim HK, Lee MW, Kim YS, Choi D, Rhim H. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes. Radiology 2014;270:888-899.CrossRef
9.
Zurück zum Zitat Dou JP, Yu J, Yang XH, Cheng ZG, Han ZY, Liu FY, Yu XL, et al. Outcomes of microwave ablation for hepatocellular carcinoma adjacent to large vessels: a propensity score analysis. Oncotarget 2017;8:28758-28768.CrossRef Dou JP, Yu J, Yang XH, Cheng ZG, Han ZY, Liu FY, Yu XL, et al. Outcomes of microwave ablation for hepatocellular carcinoma adjacent to large vessels: a propensity score analysis. Oncotarget 2017;8:28758-28768.CrossRef
10.
Zurück zum Zitat Cha DI, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, Sinn DH, et al. Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure. European Radiology 2018;29:2706-2715.CrossRef Cha DI, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, Sinn DH, et al. Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure. European Radiology 2018;29:2706-2715.CrossRef
11.
Zurück zum Zitat Wang X, Xue H-d, Jin Z-y, Su B-y, Li Z, Sun H, Chen Y, et al. Quantitative hepatic CT perfusion measurement: Comparison of Couinaud’s hepatic segments with dual-source 128-slice CT. European Journal of Radiology 2013;82:220-226. Wang X, Xue H-d, Jin Z-y, Su B-y, Li Z, Sun H, Chen Y, et al. Quantitative hepatic CT perfusion measurement: Comparison of Couinaud’s hepatic segments with dual-source 128-slice CT. European Journal of Radiology 2013;82:220-226.
12.
Zurück zum Zitat Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.CrossRef Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.CrossRef
13.
Zurück zum Zitat Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, Chen MH, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology 2014;273:241-260.CrossRef Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, Chen MH, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology 2014;273:241-260.CrossRef
14.
Zurück zum Zitat Cardella JF, Kundu S, Miller DL, Millward SF, Sacks D. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2009;20:S189-191.CrossRef Cardella JF, Kundu S, Miller DL, Millward SF, Sacks D. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2009;20:S189-191.CrossRef
15.
Zurück zum Zitat Zhang M, Liang P, Cheng ZG, Yu XL, Han ZY, Yu J. Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract. Int J Hyperthermia 2014;30:134-141.CrossRef Zhang M, Liang P, Cheng ZG, Yu XL, Han ZY, Yu J. Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract. Int J Hyperthermia 2014;30:134-141.CrossRef
16.
Zurück zum Zitat Liu FY, Yu XL, Liang P, Cheng ZG, Han ZY, Dong BW, Zhang XH. Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography. Eur J Radiol 2012;81:1455-1459.CrossRef Liu FY, Yu XL, Liang P, Cheng ZG, Han ZY, Dong BW, Zhang XH. Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography. Eur J Radiol 2012;81:1455-1459.CrossRef
17.
Zurück zum Zitat Cha DI, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, Sinn DH, et al. Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure. Eur Radiol 2019;29:2706-2715.CrossRef Cha DI, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, Sinn DH, et al. Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure. Eur Radiol 2019;29:2706-2715.CrossRef
18.
Zurück zum Zitat Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Mu MJ, Li QY, et al. Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours. Eur Radiol 2015;25:1119-1126.CrossRef Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Mu MJ, Li QY, et al. Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours. Eur Radiol 2015;25:1119-1126.CrossRef
19.
Zurück zum Zitat Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, Xiao Q. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005;235:299-307.CrossRef Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, Xiao Q. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005;235:299-307.CrossRef
20.
Zurück zum Zitat Ma S, Ding M, Li J, Wang T, Qi X, Shi Y, Ming Y, et al. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors. J Cancer Res Clin Oncol 2017;143:131-142.CrossRef Ma S, Ding M, Li J, Wang T, Qi X, Shi Y, Ming Y, et al. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors. J Cancer Res Clin Oncol 2017;143:131-142.CrossRef
21.
Zurück zum Zitat Vogl TJ, Nour-Eldin NA, Hammerstingl RM, Panahi B, Naguib NNN. Microwave Ablation (MWA): Basics, Technique and Results in Primary and Metastatic Liver Neoplasms - Review Article. Rofo 2017;189:1055-1066.CrossRef Vogl TJ, Nour-Eldin NA, Hammerstingl RM, Panahi B, Naguib NNN. Microwave Ablation (MWA): Basics, Technique and Results in Primary and Metastatic Liver Neoplasms - Review Article. Rofo 2017;189:1055-1066.CrossRef
22.
Zurück zum Zitat Hsieh YC, Limquiaco JL, Lin CC, Chen WT, Lin SM. Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations. Abdom Radiol (NY) 2019;44:1141-1151.CrossRef Hsieh YC, Limquiaco JL, Lin CC, Chen WT, Lin SM. Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations. Abdom Radiol (NY) 2019;44:1141-1151.CrossRef
23.
Zurück zum Zitat Li MD, Chen Y, Chen YX, Gao ZL, Zhu K, Yin X. [Whole-liver perfusion imaging by multi-slice spiral computed tomography based on Couinaud segments for evaluation of the blood flow state in patients with hepatitis B cirrhosis]. Zhonghua Gan Zang Bing Za Zhi 2014;22:817-821.PubMed Li MD, Chen Y, Chen YX, Gao ZL, Zhu K, Yin X. [Whole-liver perfusion imaging by multi-slice spiral computed tomography based on Couinaud segments for evaluation of the blood flow state in patients with hepatitis B cirrhosis]. Zhonghua Gan Zang Bing Za Zhi 2014;22:817-821.PubMed
24.
Zurück zum Zitat Sahani DV, Holalkere NS, Mueller PR, Zhu AX. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. Radiology 2007;243:736-743.CrossRef Sahani DV, Holalkere NS, Mueller PR, Zhu AX. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. Radiology 2007;243:736-743.CrossRef
25.
Zurück zum Zitat Tahmasebi Birgani M, Carloni V. Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy. Int J Mol Sci 2017;18. Tahmasebi Birgani M, Carloni V. Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy. Int J Mol Sci 2017;18.
26.
Zurück zum Zitat Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 2011;21:35-43.CrossRef Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 2011;21:35-43.CrossRef
27.
Zurück zum Zitat Soliman AF, Abouelkhair MM, Hasab Allah MS, El-Kady NM, Ezzat WM, Gabr HA, Elsayed EH, et al. Efficacy and Safety of Microwave Ablation (MWA) for Hepatocellular Carcinoma (HCC) in Difficult Anatomical Sites in Egyptian Patients with Liver Cirrhosis. Asian Pacific Journal of Cancer Prevention 2019;20:295-301.CrossRef Soliman AF, Abouelkhair MM, Hasab Allah MS, El-Kady NM, Ezzat WM, Gabr HA, Elsayed EH, et al. Efficacy and Safety of Microwave Ablation (MWA) for Hepatocellular Carcinoma (HCC) in Difficult Anatomical Sites in Egyptian Patients with Liver Cirrhosis. Asian Pacific Journal of Cancer Prevention 2019;20:295-301.CrossRef
28.
Zurück zum Zitat Kang TW, Lim HK, Lee MW, Kim YS, Rhim H, Lee WJ, Paik YH, et al. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study. Radiology 2016;280:300-312.CrossRef Kang TW, Lim HK, Lee MW, Kim YS, Rhim H, Lee WJ, Paik YH, et al. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study. Radiology 2016;280:300-312.CrossRef
29.
Zurück zum Zitat Liu F, Yu X, Cheng Z, Han Z, Sun Y, Liang P, Zhou F. Comparison of ultrasonography-guided percutaneous microwave ablation for subcapsular and nonsubcapsular hepatocellular carcinoma. Eur J Radiol 2017;91:93-98.CrossRef Liu F, Yu X, Cheng Z, Han Z, Sun Y, Liang P, Zhou F. Comparison of ultrasonography-guided percutaneous microwave ablation for subcapsular and nonsubcapsular hepatocellular carcinoma. Eur J Radiol 2017;91:93-98.CrossRef
Metadaten
Titel
The effect of tumor location on long-term results of microwave ablation for early-stage hepatocellular carcinoma
verfasst von
Jian-ping Dou
Zhi-yu Han
Zhi-gang Cheng
Fang-yi Liu
Xiao-ling Yu
Jie Yu
Ping Liang
Publikationsdatum
18.05.2020
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 11/2020
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-020-02472-z

Weitere Artikel der Ausgabe 11/2020

Abdominal Radiology 11/2020 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.